PR Newswire
SAN DIEGO, Feb. 21, 2017
SAN DIEGO, Feb. 21, 2017 /PRNewswire/ -- Biocept, Inc.
(NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable
information to improve the outcomes of cancer patients, announces that it will release financial results for the fourth quarter
and full year ended December 31, 2016 after the market closes on Tuesday,
March 7, 2017. Biocept management will hold a conference call for the investment community to discuss the results
and answer questions at 4:30 p.m. Eastern time (1:30 p.m. Pacific
time).
Individuals interested in participating on the conference call may do so by dialing (855) 656-0927 for domestic callers, (855)
669-9657 for Canadian callers, or (412) 902-4109 for other international callers. Those interested in listening to a webcast of
the live conference call may do so by visiting https://www.webcaster4.com/Webcast/Page/1271/19739.
A replay of the conference call will be available for 48 hours following the conclusion of the call by dialing (877) 344-7529
for domestic callers, (855) 669-9658 for Canadian callers, or (412) 317-0088 for other international callers, and entering the
replay access code 10101325. A webcast replay will be available for 90 days at http://ir.biocept.com/events.cfm.
About Biocept
Biocept, Inc. is a molecular diagnostics company with commercialized assays for lung, breast, gastric, colorectal and prostate
cancers, and melanoma. The Company uses its proprietary liquid biopsy technology to provide physicians with clinically
actionable information for treating and monitoring patients diagnosed with cancer. The Company's patented Target Selector™
liquid biopsy technology platform captures and analyzes tumor-associated molecular markers in both circulating tumor cells (CTCs)
and in circulating tumor DNA (ctDNA). With thousands of tests performed, the platform has demonstrated the ability to
identify cancer mutations and alterations to inform physicians about a patient's disease and therapeutic options. For additional
information, please visit www.biocept.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/biocept-to-release-2016-fourth-quarter-and-full-year-financial-results-and-host-investor-conference-call-on-march-7-2017-300409693.html
SOURCE Biocept, Inc.
